Where are
stem cells used?
Development of stem cell therapy
The first successful use of umbilical cord blood cells took place in France in 1988. In 2007, cord blood from FamiCord resources was used for transplantation for the first time. Since then, cord blood stem cells have been transplanted more than 85,000 times worldwide, helping to save lives and restore health for thousands of patients.
As medicine continues to advance, the number of diseases that can be treated with stem cell transplantation is steadily increasing. Today, stem cell therapy is considered a standard treatment for many conditions according to the European Society for Blood and Marrow Transplantation (EBMT) guidelines.
Discover which diseases can be treated using cord blood stem cells and learn how these therapies are shaping the future of regenerative medicine.
List of diseases treated with stem cells
acute lymphoblastic leukaemia (ALL)
acute myeloid leukaemia (AML)
acute biphenotipic leukaemia
poorly differentiated acute leukaemia
chronic myeloid leukaemia (CML)
chronic lymphocytic leukaemia (CLL)
juvenile chronic myeloid leukaemia (JCML)
juvenile myelomonocytic leukaemia (Naegeleg leukaemia) (JMML)
refractory anaemia (RA)
refractory anaemia with ringed sideroblasts (RARS)
refractory anaemia with excess blasts (RAEB)
refractory anaemia with excess blasts in transformation (RAEB-T)
chronic myelomonocytic leukaemia (CMML)
aplastic anaemia(severe)
Fanconi anaemia
paroxysmal nocturnal haemoglobinuria
acute myelofibrosis
myelofibrosis
polycythaemia vera
Essentials thromb ocythemia
non-Hodgkin lymphoma
acute lymphogranuloma
prolimphocytic leukaemia
Chediak-Higashi syndrome
chronic granulomatous disease (CGD)
neutrophil actin dysfunction
reticular dysgenesis
mucopolysaccharidoses MPS)
Scheie syndrome (MPS-IS)
Hunter syndrome (MPS-II)
Sanfilippo syndrome (MPS-III)
Morquio syndrome (MPS-IV)
Maroteaux-Lamy syndrome (MPS-VI)
Sly syndrome, beta- glucoronidase deficiency (MPS-VII)
adrenoleukodystrophy
mucolipidosis II
Krabbe disease
Gaucher disease
Niemann-Pick disease
Wolman disease
metachromatic leukodystrophy
familial erythrophagocytic lymphohistiocytosis
histiocytosis -X
hemophagocytosis
beta thalassemia
pure red cell aplasia
sickle cell anaemia
telangiectasia
Kostmann syndrome
leukocyte adhesion deficiency
DiGeorge syndrome
bare lymphocyte syndrome
Omenn syndrome
severe combined immunodeficiency (SCID)
SCID adenosine deaminase deficiency
SCID T and B lymphocytes negative
SCID T lymphocytes negative and B lymphocytes positive
common variable immunodeficiency
Wiskotta Aldrich syndrome
X-linked lymphoproliferative disorder
Lesch-Nyhan syndrome
cartilage-hair hypoplasia
Glanzmann’s thrombasthenia
osteopetrosis (marble bone disease)
mega-karyocytosis (inherited thrombocythemia)
multiple myeloma
plasmocythic leukaemia
Waldenström’s macroglobulinemia
breast cancer
Ewing’s sarcoma
neuroblastoma (sympathicoblastoma)
kidney cancer
Stem cell therapy can also benefit patients with neurological conditions, including autism and infantile cerebral palsy, offering new hope for improved quality of life.